Clinical Trial Update: Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating trastuzumab combined with pertuzumab as adjuvant therapy for breast cancer after neoadjuvant treatment is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Shengjing Hospital | Conditions: Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING